These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1067 related articles for article (PubMed ID: 16273099)
1. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Intlekofer AM; Takemoto N; Wherry EJ; Longworth SA; Northrup JT; Palanivel VR; Mullen AC; Gasink CR; Kaech SM; Miller JD; Gapin L; Ryan K; Russ AP; Lindsten T; Orange JS; Goldrath AW; Ahmed R; Reiner SL Nat Immunol; 2005 Dec; 6(12):1236-44. PubMed ID: 16273099 [TBL] [Abstract][Full Text] [Related]
2. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Pearce EL; Mullen AC; Martins GA; Krawczyk CM; Hutchins AS; Zediak VP; Banica M; DiCioccio CB; Gross DA; Mao CA; Shen H; Cereb N; Yang SY; Lindsten T; Rossant J; Hunter CA; Reiner SL Science; 2003 Nov; 302(5647):1041-3. PubMed ID: 14605368 [TBL] [Abstract][Full Text] [Related]
3. Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-β1 signaling. Grange M; Verdeil G; Arnoux F; Griffon A; Spicuglia S; Maurizio J; Buferne M; Schmitt-Verhulst AM; Auphan-Anezin N J Immunol; 2013 Oct; 191(7):3712-24. PubMed ID: 24006458 [TBL] [Abstract][Full Text] [Related]
4. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. Intlekofer AM; Takemoto N; Kao C; Banerjee A; Schambach F; Northrop JK; Shen H; Wherry EJ; Reiner SL J Exp Med; 2007 Sep; 204(9):2015-21. PubMed ID: 17698591 [TBL] [Abstract][Full Text] [Related]
5. Eomesodermin driven IL-10 production in effector CD8 Reiser J; Sadashivaiah K; Furusawa A; Banerjee A; Singh N Cell Immunol; 2019 Jan; 335():93-102. PubMed ID: 30528350 [TBL] [Abstract][Full Text] [Related]
6. The Tec family tyrosine kinases Itk and Rlk regulate the development of conventional CD8+ T cells. Atherly LO; Lucas JA; Felices M; Yin CC; Reiner SL; Berg LJ Immunity; 2006 Jul; 25(1):79-91. PubMed ID: 16860759 [TBL] [Abstract][Full Text] [Related]
7. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. Sutherland AP; Joller N; Michaud M; Liu SM; Kuchroo VK; Grusby MJ J Immunol; 2013 Apr; 190(8):3977-84. PubMed ID: 23479229 [TBL] [Abstract][Full Text] [Related]
8. CD27low natural killer cells prolong allograft survival in mice by controlling alloreactive CD8+ T cells in a T-bet-dependent manner. Lantow M; Eggenhofer E; Sabet-Baktach M; Renner P; Rovira J; Koehl GE; Schlitt HJ; Geissler EK; Kroemer A Transplantation; 2015 Feb; 99(2):391-9. PubMed ID: 25606781 [TBL] [Abstract][Full Text] [Related]
10. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. Banerjee A; Gordon SM; Intlekofer AM; Paley MA; Mooney EC; Lindsten T; Wherry EJ; Reiner SL J Immunol; 2010 Nov; 185(9):4988-92. PubMed ID: 20935204 [TBL] [Abstract][Full Text] [Related]
11. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation. Rao RR; Li Q; Gubbels Bupp MR; Shrikant PA Immunity; 2012 Mar; 36(3):374-87. PubMed ID: 22425248 [TBL] [Abstract][Full Text] [Related]
12. A color-coded reporter model to study the effect of immunosuppressants on CD8+ T-cell memory in antitumor and alloimmune responses. Rovira J; Sabet-Baktach M; Eggenhofer E; Lantow M; Koehl GE; Schlitt HJ; Campistol JM; Geissler EK; Kroemer A Transplantation; 2013 Jan; 95(1):54-62. PubMed ID: 23222894 [TBL] [Abstract][Full Text] [Related]
13. N-ras couples antigen receptor signaling to Eomesodermin and to functional CD8+ T cell memory but not to effector differentiation. Iborra S; Ramos M; Arana DM; Lázaro S; Aguilar F; Santos E; López D; Fernández-Malavé E; Del Val M J Exp Med; 2013 Jul; 210(7):1463-79. PubMed ID: 23776078 [TBL] [Abstract][Full Text] [Related]
14. CD70 and IFN-1 selectively induce eomesodermin or T-bet and synergize to promote CD8+ T-cell responses. Dong H; Franklin NA; Ritchea SB; Yagita H; Glennie MJ; Bullock TN Eur J Immunol; 2015 Dec; 45(12):3289-301. PubMed ID: 26461455 [TBL] [Abstract][Full Text] [Related]
15. FOXO1 opposition of CD8 Delpoux A; Lai CY; Hedrick SM; Doedens AL Proc Natl Acad Sci U S A; 2017 Oct; 114(42):E8865-E8874. PubMed ID: 28973925 [TBL] [Abstract][Full Text] [Related]
16. The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin. Rao RR; Li Q; Odunsi K; Shrikant PA Immunity; 2010 Jan; 32(1):67-78. PubMed ID: 20060330 [TBL] [Abstract][Full Text] [Related]
17. IL-15 Complexes Induce Migration of Resting Memory CD8 T Cells into Mucosal Tissues. Sowell RT; Goldufsky JW; Rogozinska M; Quiles Z; Cao Y; Castillo EF; Finnegan A; Marzo AL J Immunol; 2017 Oct; 199(7):2536-2546. PubMed ID: 28814601 [TBL] [Abstract][Full Text] [Related]
18. Dicer Regulates the Balance of Short-Lived Effector and Long-Lived Memory CD8 T Cell Lineages. Baumann FM; Yuzefpolskiy Y; Sarkar S; Kalia V PLoS One; 2016; 11(9):e0162674. PubMed ID: 27627450 [TBL] [Abstract][Full Text] [Related]
19. T-bet and eomesodermin are required for T cell-mediated antitumor immune responses. Zhu Y; Ju S; Chen E; Dai S; Li C; Morel P; Liu L; Zhang X; Lu B J Immunol; 2010 Sep; 185(6):3174-83. PubMed ID: 20713880 [TBL] [Abstract][Full Text] [Related]
20. T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate. Mackay LK; Wynne-Jones E; Freestone D; Pellicci DG; Mielke LA; Newman DM; Braun A; Masson F; Kallies A; Belz GT; Carbone FR Immunity; 2015 Dec; 43(6):1101-11. PubMed ID: 26682984 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]